(Q95410318)

English

Is the combination of neutrophil to lymphocyte and platelet to lymphocyte ratios a useful predictor of treatment response and prognosis in patients with non-small cell lung cancer?

No description defined

In more languages
default for all languages
No label defined

No description defined

Statements

Is the combination of neutrophil to lymphocyte and platelet to lymphocyte ratios a useful predictor of treatment response and prognosis in patients with non-small cell lung cancer? (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit